|
|
|
|
||
Re: Peak Sales for PDP, Dementia, Negative Symptoms...On
timing to peak sales, hard to say precisely. Approval timeline is
reasonably likely for 2H 2020 - if no surprises - given what company has said. So ramp starts
then; 2021 to build out sales force to 500 from 150, so perhaps 2022 when we
start to see really large effects, and be able to better est peak sales. But also note that peak stock price may occur before actual peak sales given the anticipatory nature of the stock market. On stock price, assuming 150m shares outstanding, i.e., no new cap raises: US + EU for DRP say is peak ~9B annual; EU being a year or 2 after US as filing in EU would likely not occur until after DRP approval. So then its a choose your multiple: 2x
sales: 18b/150m = 120 4x
sales: 36b/150m = 240 8x sales: 72b/150m = 480
etc
|
return to message board, top of board |